期刊文献+

PET/CT在骨转移癌中的应用

下载PDF
导出
摘要 目的:探讨18氟-脱氧葡萄糖(18F-FDG)PET/CT显像在骨转移癌诊断中的应用价值。方法:回顾性分析2008年~2010年间,经随访临床诊断为骨转移癌的15例患者,全部行18F-FDGPET/CT检查,分析患者的影像资料和化验检查,结合病理结果,探讨18F-FDGPET/CT在确定骨转移癌诊断中的作用。结果:14例患者18F-FDGPET/CT明确诊断为骨转移癌,其中11例明确诊断原发病灶,另2例结合化验检查和病理活检明确病变来源,1例经多次活检,结合免疫组织化学染色最终确诊,1例经临床随访证实骨转移癌。MRI诊断骨转移癌8例,CT诊断骨转移癌6例,核素显像5例明确诊断为转移癌,平片仅诊断2例;确诊转移的病例中,MRI找到原发灶3例,CT找到原发灶5例,核素显像和平片均未显示原发病灶。结论:充分发挥18F-FDGPET/CT的优势,不仅可以诊断骨转移癌,还可以寻找原发灶,是骨转移癌患者确诊的首选检查手段。
出处 《吉林医学》 CAS 2010年第17期2587-2588,共2页 Jilin Medical Journal
  • 相关文献

参考文献7

  • 1Rybak LD,Rosenthal DI.Radiological imaging for the diagnosis of bone mestases[J].Q J Nuel Med,2001,45(1):53.
  • 2Thanapprapasr D,Nartthanarung A,Likittanasombut P,et al.Bone metastasis in cervical cancer patients over a 10-year period[J].Int J Gynecol Cancer,2010,20(3):373.
  • 3贾连顺,陈华江.脊柱转移瘤外科诊断治疗的现状与进展[J].中华骨科杂志,2003,23(6):331-334. 被引量:21
  • 4Tímár J.Molecular basis of bone metastasis formation and its targeted therapy[J].Magy Onkol,2010,54(1):59.
  • 5Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imaging in metastatic breast cancer[J].J Clin Oncol,2004,22(15):2942.
  • 6Blake GM,Park-Holohan SJ,Cook GJ,et al.Quantitative studies of bone with the use of 18F-fluoride and 99mTc thylene diphosphonate[J].Semin Nucl Med,2001,31(15):2849.
  • 7张驰,周前,陈永辉,李方.^(18)F-FDGPET与^(99)Tc^m-MDP显像诊断肿瘤骨转移的比较[J].中华核医学杂志,2003,23(4):201-203. 被引量:16

二级参考文献28

  • 1程午樱 见:丁虹 赵军 管一晖 主编.G-CSF影响骨髓^18F-FDG摄取一例[A].见:丁虹,赵军,管一晖,主编.PET临床病例精选[C].香港:雅艺出版设计公司,2002.176.178.
  • 2Hsia TC, Shen YY, Yen RF, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma, 2002, 49: 267-271.
  • 3Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with ^99Tc^m-MDP bone scintigraphy. Nucl Med Commun, 2001, 22: 875-879.
  • 4Yang SN, Liang JA, Lin FJ, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol, 2002, 128: 325-328.
  • 5Chung JK, Kim YK, Yoon JK, et al. Diagnostic usefulness of ^18F-FDG whole body PET in detection of bony metastases compared to ^99Tc^m-MDP bone scan. J Nucl Med, 1999, 40: 96P.
  • 6Shreve PD, Grossman HB, Gross MD, et al. Metastatic prostate cancer:initial findings of PET with 2-deoxy-2-^18F-fluoro-D-glucose. Radiology,1996, 199: 751-756.
  • 7Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by ^18F-FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol, 1998, 16: 3375-3379.
  • 8Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children mad young adults: comparison with skeletal scintigraphy and FDG PET. Am J Roentgenol, 2001, 177:229-236.
  • 9Gulenchyn KY, Papoff W. ^99Tc^m-MDP scintigraphy: an insensitive tool for the detection of bone marrow metastases. Clin Nucl Med, 1987, 12: 45-46.
  • 10Wise JJ, Fischgrund JS, Herkowitz HN, et al. Complication, surivival rates, and risk factors of surgery for metastatic disease of the spine. Spine, 1999, 24: 1943-1951.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部